Freshpaint can help Abbott’s marketing team restore visibility across your digital campaigns, without exposing patient data. Track what’s working, reduce wasted spend, and stay compliant on Google, Meta, TikTok, and more.
Drive More Leads Without Legal Risk: Run high-performing campaigns on Meta, Google, TikTok and more—without violating HIPAA or CCPA. Freshpaint replaces risky tracking pixels and strips out PHI before it hits your ad tools.
Capture Intent Not PHI: Safely track form fills, brochure downloads, webinar attendance and provider searches, then sync signals to your CRM.
Marketing That Legal and IT Can Actually Say Yes To: Freshpaint’s FDA- and HIPAA-aware infrastructure is designed for medical device and DTC healthcare marketing.
Was Abbott forced to shut off tracking tools after a legal review? You’re not alone, and you’re not out of options.
When pixels disappeared, so did your visibility. Leads dropped. Acquisition costs rose. But your performance marketing doesn’t have to suffer. Freshpaint can help Abbott restore end-to-end tracking for D2C campaigns, while keeping patient data private and staying HIPAA and CCPA compliant.
You’re investing in performance marketing, but how much of that performance is disappearing into the dark?
Freshpaint can help Abbott safely reclaim visibility, restoring the behavioral data needed for effective targeting while staying HIPAA-compliant.
Try our ROI calculator to see what you’re leaving on the table.
Arden Kaley, VP Growth Marketing

Generate a comprehensive scan of all the pages on Abbott's domain(s) to audit what trackers are running where, so you can quickly make the decisions that keep you compliant with data privacy laws and HIPAA.
When a global diabetes brand was forced to remove the Meta Pixel, they lost 90% of leads and saw CPL spike 10x. With Freshpaint, they rebuilt attribution, restored performance, and cut CPL back down — turning compliance into a competitive comeback.